Transplant company Magenta plans $100M listing

Stem cell transplant company Magenta Therapeutics Inc. (Cambridge, Mass.) filed on May 24 to raise up to $100 million in an

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE